Skip to content
Veltassa(patiromer)
Veltassa (patiromer) is a small molecule pharmaceutical. Patiromer was first approved as Veltassa on 2015-10-21. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
Veltassa
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Patiromer sorbitex calcium
Tradename
Company
Number
Date
Products
VELTASSAViforN-205739 RX2015-10-21
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
veltassaNew Drug Application2020-11-30
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
hyperkalemiaHP_0002153D006947E87.5
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Patiromer Sorbitex Calcium, Veltassa, Vifor Pharma
94924762033-10-08U-1766
99252122033-10-08U-1766
111233632033-10-08U-1766
83378242030-05-29DPU-1766
81478732028-06-20DP
82829132027-05-29DP
82165602027-03-14U-1766
75567992025-02-27U-1766
82878472024-03-30U-1766
84757802024-03-30U-1766
87783242024-03-30U-1766
88891152024-03-30U-1766
104858212024-03-30U-1766
ATC Codes
V: Various drug classes in atc
V03: All other therapeutic products
V03A: All other therapeutic products
V03AE: Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE09: Patiromer calcium
HCPCS
No data
Clinical
Clinical Trials
25 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperkalemiaD006947HP_0002153E87.573717
Chronic renal insufficiencyD051436N1812115
Heart failureD006333EFO_0003144I502114
Chronic kidney failureD007676EFO_0003884N18.6123
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I1022
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePATIROMER
INNpatiromer calcium
Description
Patiromer, sold under the brand name Veltassa, is a medication used to treat high blood potassium. It is taken by mouth. It works by binding potassium in the gut.
Classification
Small molecule
Drug classpolymers; antihyperlipidemic, thyromimetic derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID1260643-52-4
RxCUI1716203
ChEMBL IDCHEMBL2107875
ChEBI ID
PubChem CID
DrugBankDB09263
UNII ID7T97I3787N (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 525 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
192 adverse events reported
View more details